首页> 外国专利> Cardioprotective medicinal preparations comprising amiodarone, a nitro derivative and optionally a beta-blocker

Cardioprotective medicinal preparations comprising amiodarone, a nitro derivative and optionally a beta-blocker

机译:包含胺碘酮,硝基衍生物和可选的β-受体阻滞剂的心脏保护性药物制剂

摘要

The invention relates to pharmaceutical preparations which combine, in several forms, as active substances, either 1 amiodarone and a nitro derivative and optionally a beta-blocker, or 2 amiodarone and a beta-blocker and optionally a nitro derivative. This pharmaceutical preparation in oral and parenteral forms, containing, apart from standard excipients or adjuvants, in the weight ratios defined by the inventor, amiodarone combined with isosorbide dinitrate, or with trinitrin and/or atenolol, acebutolol or metoprolol, exerts a cardioprotective action that makes it possible, in acute coronary insufficiency, to prevent myocardial infarction in some cases, its extension in most cases and sudden death generally. In acute coronary insufficiency, it permits, in some cases, an efficacy greater than that of either of the components administered alone and/or a decrease in side effects through the use of a lower dosage. It permits an improvement in the quality of life.
机译:本发明涉及药物制剂,该药物制剂以几种形式将1种胺碘酮和硝基衍生物和任选的β-阻滞剂或2种胺碘酮和β-阻断剂和任选的硝基衍生物结合作为活性物质。这种口服和非肠道形式的药物制剂,除了标准的赋形剂或佐剂外,还以发明人定义的重量比含有胺碘酮与硝酸异山梨酯或三硝酸甘油酯和/或阿替洛尔,醋丁酚或美托洛尔联用,具有保护心脏的作用,在急性冠状动脉供血不足的情况下,有可能在某些情况下防止心肌梗塞,在大多数情况下可以扩大心肌梗塞,并通常导致猝死。在急性冠状动脉供血不足中,在某些情况下,它的疗效高于单独施用的任何一种组分的效果,和/或通过使用较低剂量降低了副作用。它可以改善生活质量。

著录项

  • 公开/公告号FR2626176A1

    专利类型

  • 公开/公告日1989-07-28

    原文格式PDF

  • 申请/专利权人 BALIGADOO SOORIANARAIN;

    申请/专利号FR19880000787

  • 发明设计人

    申请日1988-01-25

  • 分类号A61K31/34;

  • 国家 FR

  • 入库时间 2022-08-22 06:29:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号